{"product_id":"sodium-ferric-gluconate-complex-in-sucrose-injection-62-5mg","title":"Sodium Ferric Gluconate Complex in Sucrose Injection 62.5mg SDV 5mL 10\/Pack (RX)","description":"\u003ch1\u003eSodium Ferric Gluconate Complex in Sucrose Injection 62.5 mg\u003c\/h1\u003e\n\u003cp\u003e\u003cstrong\u003eOverview:\u003c\/strong\u003e Sodium ferric gluconate complex in sucrose injection is a prescription \u003cem\u003eintravenous iron supplement\u003c\/em\u003e formulated to rapidly replenish iron stores and boost hemoglobin and red blood cell production. This iron infusion contains \u003cstrong\u003e62.5 mg elemental iron per 5 mL single-dose vial\u003c\/strong\u003e (12.5 mg\/mL), in a stable ferric (Fe³⁺)–gluconate–sucrose complex. By delivering iron directly into the bloodstream, it overcomes the limitations of oral iron (poor absorption or gastrointestinal side effects) and is specifically FDA-indicated for \u003cstrong\u003eiron deficiency anemia in chronic kidney disease (CKD) patients on hemodialysis who are also receiving epoetin therapy\u003c\/strong\u003e. This medical-grade iron infusion is shipped as a pack of 10 vials (single-use each) for use under physician supervision. When administered correctly, it helps restore iron levels, improve hemoglobin (Hgb), and alleviate anemia symptoms (fatigue, weakness) by supporting healthy red blood cell production.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eKey features:\u003c\/strong\u003e Each 5 mL vial contains 62.5 mg of elemental iron as the sodium salt of ferric gluconate in 20% w\/v sucrose. Sodium ferric gluconate (generic) is the active ingredient (also marketed under the brand name \u003cem\u003eFerrlecit\u003c\/em\u003e in the US) and is provided in a clear, dark brown aqueous solution. This \u003cstrong\u003eintravenous iron therapy\u003c\/strong\u003e is administered either as a slow infusion or injection during dialysis. Because it contains \u003cstrong\u003ebenzyl alcohol\u003c\/strong\u003e (9 mg\/mL), it is not recommended for neonates. The solution is supplied in \u003cstrong\u003esingle-dose vials\u003c\/strong\u003e—use one vial per intravenous dose and discard any unused portion. Store at controlled room temperature (68–77°F) and protect from freezing. \u003cstrong\u003ePrescription Only:\u003c\/strong\u003e This product must be administered by qualified healthcare professionals in a clinical setting.\u003c\/p\u003e\n\u003ch2\u003eUses and Applications\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eTreat Iron Deficiency Anemia:\u003c\/strong\u003e Specifically indicated for iron deficiency anemia in adult and pediatric patients (≥6 years) with chronic kidney disease on hemodialysis who are receiving supplemental epoetin (erythropoiesis-stimulating agent) therapy. It replenishes iron stores, allowing the body to produce hemoglobin and healthy red blood cells.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eRapid Iron Repletion:\u003c\/strong\u003e Ideal for patients who cannot tolerate or absorb oral iron (e.g. gastrointestinal issues, inflammatory bowel disease, or CKD). By intravenous infusion, iron is delivered directly to the bloodstream, providing \u003cem\u003efast correction\u003c\/em\u003e of anemia and reducing fatigue.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eDialysis Center Use:\u003c\/strong\u003e Commonly used in hemodialysis clinics and hospitals. During dialysis sessions, the iron solution can be given in tandem with routine care to improve patient iron levels without extra clinic visits. It’s often prescribed when lab tests show low ferritin or transferrin saturation (TSAT) despite oral iron.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eNutrient Infusion Therapy:\u003c\/strong\u003e As a blood-building nutrient injection, it helps support \u003cstrong\u003eoxygen transport\u003c\/strong\u003e throughout the body. Iron is critical for hemoglobin\/myoglobin synthesis to maintain oxygen delivery to tissues. This injection \u003cem\u003efortifies blood health\u003c\/em\u003e and energy levels in anemic patients, aligning with overall wellness goals for CKD-related anemia management.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003eSpecifications\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eGeneric Name:\u003c\/strong\u003e Sodium Ferric Gluconate Complex in Sucrose (iron gluconate injection)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBrand Name:\u003c\/strong\u003e (e.g. Ferrlecit®) – generic product is bioequivalent.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eActive Ingredient:\u003c\/strong\u003e Ferric (Fe³⁺) gluconate with sucrose stabilizer.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStrength:\u003c\/strong\u003e 62.5 mg elemental iron per 5 mL vial (12.5 mg\/mL).\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFormulation:\u003c\/strong\u003e Clear, dark brown sterile solution for intravenous injection. Each mL contains 9 mg benzyl alcohol (preservative). pH ~7.7–9.7.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePackaging:\u003c\/strong\u003e Box of 10 single-dose 5 mL vials (NDC may vary by manufacturer). Each vial is for one-time use only.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAdministration Route:\u003c\/strong\u003e Intravenous infusion or slow IV push (i.e. \u003cem\u003evenous injection into bloodstream\u003c\/em\u003e).\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStorage:\u003c\/strong\u003e Room temperature (68–77°F); do not freeze. Protect from light\/shocks. Use immediately after preparation.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eRegulatory:\u003c\/strong\u003e FDA-approved iron replacement therapy. Prescription drug only (requires licensed healthcare provider).\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003eHow to Use\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eMedical Supervision:\u003c\/strong\u003e Administer this IV iron injection only in a clinical setting (hospital\/dialysis clinic) under the guidance of trained medical staff. Ensure resuscitation equipment is available for allergic reactions.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePreparation:\u003c\/strong\u003e Inspect vial for particulate matter\/discoloration. Use only if solution is clear and vial intact. Withdraw the calculated dose using aseptic technique and dilute in 0.9% sodium chloride (normal saline) compatible with label instructions. \u003cem\u003eDo not mix with other medications or dextrose solutions; dilute only in normal saline.\u003c\/em\u003e Shake gently to mix, and \u003cstrong\u003euse immediately after dilution\u003c\/strong\u003e. Discard any unused portion.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eInfusion\/Injection:\u003c\/strong\u003e Connect IV line to patient’s access (e.g. venous line). Administer dose \u003cem\u003eslowly\u003c\/em\u003e as follows:\n\u003cul\u003e\n\u003cli\u003e\n\u003cem\u003eIV Infusion:\u003c\/em\u003e Dilute the vial(s) in 100 mL of 0.9% NaCl. Infuse over approximately \u003cstrong\u003e1 hour\u003c\/strong\u003e per hemodialysis session.\u003c\/li\u003e\n\u003cli\u003e\n\u003cem\u003eSlow IV Push:\u003c\/em\u003e If instructed, the undiluted 10 mL (125 mg) dose may be given via slow IV injection (not faster than 12.5 mg\/minute, i.e. ~8 minutes per 10 mL) at the end of dialysis.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMonitoring:\u003c\/strong\u003e Check patient’s blood pressure and status during and after administration. Observe for signs of allergy or hypotension as noted below. Adjust infusion rate if necessary.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eDosage Calculations:\u003c\/strong\u003e Confirm dose using 62.5 mg per 5 mL concentration; do not exceed recommended volume. Use the exact volume prescribed (e.g. 10 mL = 125 mg elemental iron).\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003eDosage and Administration\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eAdult Patients:\u003c\/strong\u003e The typical repletion dose is \u003cstrong\u003e125 mg elemental iron (10 mL)\u003c\/strong\u003e per hemodialysis session. This dose may be given diluted over 1 hour or slow IV push (12.5 mg\/min). For most patients, a total course of about 1,000 mg (eight 125 mg doses) over successive dialysis visits is needed to correct anemia levels. After iron stores are replete, maintenance doses (e.g. 125 mg monthly) may be used to keep hemoglobin and serum ferritin in target range.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePediatric Patients (≥6 years):\u003c\/strong\u003e Dose is \u003cstrong\u003e1.5 mg\/kg of elemental iron\u003c\/strong\u003e (0.12 mL\/kg), up to 125 mg, given diluted in 25 mL NS over 1 hour per dialysis. Do not exceed 125 mg per dose. Multiple doses over 8 sessions are typically required for full repletion. Safety\/efficacy in children \u0026lt;6 years not established.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAdministration Details:\u003c\/strong\u003e Administer during or immediately after dialysis session. Do \u003cstrong\u003enot\u003c\/strong\u003e combine the injection with parenteral nutrition or other IV drugs. Always use the vial solution as soon as drawn and complete infusion before the end of dialysis hour.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003eDrug Interactions\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eNo Known Major Interactions:\u003c\/strong\u003e Formal drug–interaction studies have not identified significant interactions with sodium ferric gluconate infusion. Iron infusion bypasses the gut, so oral absorption interactions (with tetracyclines, fluoroquinolones, levothyroxine, etc.) are minimized, but it is still advisable to \u003cem\u003einform the physician of all medications and supplements\u003c\/em\u003e being taken.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCoadministration Caution:\u003c\/strong\u003e Calcium, magnesium, antacids, and certain antibiotics can bind iron if given orally; these are usually spaced apart when oral iron is used. With IV iron, this is less of a concern, but check labels of each medication. In all cases, ensure compatibility; \u003cem\u003edo not mix in the same IV line\u003c\/em\u003e with anything other than normal saline.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eErythropoietin Agents:\u003c\/strong\u003e No direct negative interaction – in fact, sodium ferric gluconate is intended to be used with epoetin (EPO) to achieve better anemia control. Continue monitoring blood counts and iron studies to adjust doses of erythropoiesis-stimulating agents accordingly.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003eSide Effects\u003c\/h2\u003e\n\u003cp\u003eCommon side effects are generally mild to moderate and may include:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eGastrointestinal discomfort:\u003c\/strong\u003e nausea, vomiting, or diarrhea. These may occur during or shortly after infusion.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eInjection site reactions:\u003c\/strong\u003e pain, burning, swelling, or irritation at the site of IV infusion.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFlushing or Hypotension:\u003c\/strong\u003e transient low blood pressure (hypotension) can cause dizziness, faintness, or headache. Conversely, some patients may experience transient hypertension (rise in blood pressure) after infusion. Vital signs should be monitored during administration.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMusculoskeletal:\u003c\/strong\u003e cramps or pain in legs or abdomen.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eRespiratory\/General:\u003c\/strong\u003e shortness of breath, chest pain, general malaise, or unusual sensations (e.g. headache, fatigue, rash).\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAllergic Reactions:\u003c\/strong\u003e Itching, hives, swelling, or asthma-like symptoms can occur, typically during the infusion. \u003cem\u003eSerious\u003c\/em\u003e (rare): anaphylaxis (life-threatening allergic reaction) is possible. Symptoms include difficulty breathing, throat tightness, rapid heartbeat, or severe hypotension – \u003cstrong\u003eseek emergency care immediately\u003c\/strong\u003e.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eOther:\u003c\/strong\u003e Back pain, leg pain, or fever have been reported. Report any unexpected symptoms to a healthcare provider.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eIf severe side effects occur (e.g. passing out, chest pain, trouble breathing, confusion), stop the infusion and get medical help right away. For any concerns during infusion, notify medical staff immediately.\u003c\/p\u003e\n\u003ch2\u003eWarnings and Precautions\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eHypersensitivity (Allergy\/Anaphylaxis):\u003c\/strong\u003e Serious allergic reactions can occur, especially on first dose. \u003cem\u003eInfuse only in a setting equipped for resuscitation and monitor patient closely for at least 30 minutes after infusion completion.\u003c\/em\u003e Discontinue if signs of anaphylaxis (rash, bronchospasm, hypotension) appear.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eHypotension:\u003c\/strong\u003e Sodium ferric gluconate may cause drops in blood pressure. Infuse slowly and monitor. If hypotension occurs, slow or stop the infusion and manage supportively (e.g. IV fluids) as needed.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eIron Overload:\u003c\/strong\u003e Over-treatment can lead to iron overload and related organ damage. \u003cstrong\u003eDo not use\u003c\/strong\u003e in patients with known hemosiderosis, hemochromatosis, or other iron storage disorders. Before each dose, check hemoglobin, ferritin, and TSAT. Do not exceed recommended dosing unless guided by lab values and specialist advice.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eContraindications:\u003c\/strong\u003e Do not give to anyone with a history of serious allergic reaction to iron gluconate or any component of the injection. Also avoid use in anemia not caused by iron deficiency (e.g. hemolytic anemia, bone marrow disorders) as it offers no benefit and poses risk.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eNeonates and Pediatrics:\u003c\/strong\u003e Contains benzyl alcohol; \u003cstrong\u003enot for use in neonates or infants\u003c\/strong\u003e (risk of “gasping syndrome”). Safety in children under 6 yrs is not established. Use with caution and dosing by weight in older children.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePregnancy and Lactation:\u003c\/strong\u003e Use only if clearly needed during pregnancy. Risk of hypersensitivity to fetus is unknown. Iron is essential in pregnancy, but the decision should balance maternal benefit vs. potential fetal risk. Not known if excreted in breast milk; discuss with physician before breastfeeding.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eOther Precautions:\u003c\/strong\u003e Store properly; discard if frozen or contaminated. Monitor iron levels periodically; resume maintenance treatment only when iron stores fall or anemia recurs. Patients with acute or chronic infections should be monitored closely, as iron can theoretically promote bacterial growth. Avoid overdose – fatal iron toxicity can occur in children if accidentally ingested.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eWARNING:\u003c\/strong\u003e \u003cem\u003eThis is a potent prescription iron medication. Use only under medical supervision with appropriate monitoring.\u003c\/em\u003e\u003c\/p\u003e","brand":"Hikma Injectables","offers":[{"title":"Default Title","offer_id":53924027466096,"sku":"00143957010","price":369.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/Sodium-Ferric-Gluconate-Complex-in-Sucrose-Injectio.jpg?v=1781789901","url":"https:\/\/www.mountainside-medical.com\/products\/sodium-ferric-gluconate-complex-in-sucrose-injection-62-5mg","provider":"Mountainside Medical","version":"1.0","type":"link"}